Maze Therapeutics, Inc. (MAZE)
47.77
+2.74
(+6.08%)
USD |
NASDAQ |
Feb 09, 16:00
48.64
+0.87
(+1.82%)
After-Hours: 19:15
Maze Therapeutics EPS Diluted (Quarterly) : -0.6258 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CDT Equity, Inc. | -13.16 |
| LENZ Therapeutics, Inc. | -0.5851 |
| Liminatus Pharma, Inc. | -0.0675 |
| Oruka Therapeutics, Inc. | -0.6871 |
| MapLight Therapeutics, Inc. | -0.6484 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -30.09M |
| Total Expenses (Quarterly) | 30.09M |
| Enterprise Value | 1.807B |
| Earnings Yield | -4.72% |
| Normalized Earnings Yield | -4.677 |